Komori
Chemipro Kasei (4960) · InitiativeDelay in new product sales plan

Development of New Products and Processes Using Proprietary Technologies

First written in FY2016. 29 of 31 entries say "Restated". Latest entry: FY2026.

31entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20262016: 120162017: 320172018: 320182019: 320192020: 420202021: 420212022: 420222023: 420232024: 220242025: 220252026: 12026
Same theme, other companies
New Product Development in Advanced and Functional Materials and Pharmaceutical IntermediatesA theme 11 companies write about · 0 as a headwind · 12 as a tailwind

The whole theme swung hardest in 2023: 2 of 10 companies on the "Worse" side.

0 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Delay in new product sales planAnnual report

    「The new product, which was expected to be sold during the fiscal year, was not recognized as revenue during the current fiscal year because production was delayed by difficulties in procuring raw materials.」

    Sales of the new product had been expected during the fiscal year, but revenue was not recognized because of difficulties in procuring raw materials and production delays. R&D itself is continuing.
  2. FY2026-H1RestatedAnnual report

    「The amount spent on R&D activities during the interim accounting period was ¥128 million. There were no material changes in the status of the company's R&D activities during the interim accounting period.」

    The company recorded ¥128 million in R&D expenses and stated that there were no material changes in the status of its R&D activities.
  3. FY2025RestatedAnnual report

    「The company continues to develop new products and manufacturing processes, including plastic additives such as ultraviolet absorbers and electronic materials such as organic electroluminescence (organic EL) materials. For ultraviolet absorbers, it is developing various new products, including benzotriazole- and triazine-based products, while improving the production efficiency of existing products. For organic EL materials, it is conducting R&D on the synthesis and physical property evaluation of new materials, including electron-transport, hole-transport, emissive and host materials, as well as improving the production efficiency of existing products. The company is also jointly developing perovskite solar cells and other products with the National Institute of Advanced Industrial Science and Technology.」

    The company continues to develop new products and manufacturing processes using proprietary technologies and through industry-academic collaboration, and has also disclosed joint development of perovskite solar cells and other products with the National Institute of Advanced Industrial Science and Technology. R&D expenses were ¥243 million, and R&D personnel numbered 21.
  4. FY2025-H1RestatedAnnual report

    「The amount spent on R&D activities during the interim accounting period was ¥123 million. There were no material changes in the status of the company's R&D activities during the interim accounting period.」

    The company recorded R&D expenses of ¥123 million and states that there were no material changes in its R&D activities.
  5. FY2024-Q3RestatedAnnual report

    「The amount spent on R&D activities during the third-quarter cumulative period was ¥152 million. There were no material changes in the status of the company's R&D activities during the third-quarter cumulative period.」

    The company recorded R&D expenses of ¥152 million and states that there were no material changes in its R&D activities.
  6. FY2024-Q2RestatedAnnual report

    「The amount spent on R&D activities during the second-quarter cumulative period was ¥109 million. There were no material changes in the status of the company's R&D activities during the second-quarter cumulative period.」

    The company states that there were no material changes in its R&D activities and discloses R&D expenses of ¥109 million for the second-quarter cumulative period.
  7. FY2024-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥56 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    R&D expenses for the first-quarter cumulative period were ¥56 million, and the company states that there were no material changes in its R&D activities.
  8. FY2023RestatedAnnual report

    「During the fiscal year, the Company continued developing new products and production processes related to electronic materials, including plastic additives such as ultraviolet absorbers and organic electroluminescent (organic EL) materials.」

    The company continues joint industry-academic research, the development of new products and manufacturing processes using proprietary technologies, improvements in the production efficiency of ultraviolet absorbers, and the synthesis, physical property evaluation and production-efficiency improvements of organic EL materials. R&D expenses were ¥217 million.
  9. FY2023-Q3RestatedAnnual report

    「Research and development expenses for the third quarter cumulative period were ¥155 million. There were no material changes in the status of the Company's research and development activities during the third quarter cumulative period.」

    The Company recorded research and development expenses of ¥155 million and stated that there were no material changes in the status of its research and development activities.
  10. FY2023-Q2RestatedAnnual report

    「Research and development expenses for the second quarter cumulative period were ¥100 million. There were no material changes in the status of the Company's research and development activities during the second quarter cumulative period.」

    The Company recorded research and development expenses of ¥100 million and stated that there were no material changes in the status of its research and development activities.
  11. FY2023-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥49 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    Recorded R&D expenditure of ¥49 million and stated that there were no material changes in the status of R&D activities.
  12. FY2022RestatedAnnual report

    「To expand its business and strengthen and stabilize its management base, the Company is promoting stronger collaboration with government and academic institutions, conducting research and development across a range of fields, including electronic materials such as ultraviolet absorbers and organic electroluminescent (organic EL) materials, and advancing the development of new products by fully utilizing its proprietary technologies.」

    The Company continued collaborating with government and academic institutions, developing new products and production processes using proprietary technologies, improving production efficiency for ultraviolet absorbers, and synthesizing and evaluating the physical properties of organic EL materials. Research and development expenses were ¥220 million, and the research and development staff numbered 18.
  13. FY2022-Q3RestatedAnnual report

    「Research and development expenses for the third quarter cumulative period were ¥152 million. There were no material changes in the status of the Company's research and development activities during the third quarter cumulative period.」

    The Company disclosed research and development expenses of ¥152 million for the third quarter cumulative period, stating that there were no material changes in its research and development activities.
  14. FY2022-Q2RestatedAnnual report

    「Research and development expenses for the second quarter cumulative period were ¥89 million. There were no material changes in the status of the Company's research and development activities during the second quarter cumulative period.」

    The Company disclosed research and development expenses of ¥89 million for the second quarter cumulative period, stating that there were no material changes in its research and development activities.
  15. FY2022-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥44 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    The Company disclosed research and development expenses of ¥44 million for the first quarter cumulative period, stating that there were no material changes in its research and development activities.
  16. FY2021RestatedAnnual report

    「To expand its business and strengthen and stabilize its management base, the Company is promoting stronger collaboration with government and academic institutions, conducting research and development across a range of fields, including electronic materials such as ultraviolet absorbers and organic electroluminescent (organic EL) materials, and advancing the development of new products by fully utilizing its proprietary technologies.」

    The Company continued collaborating with government and academic institutions, developing new products using proprietary technologies, improving production efficiency for ultraviolet absorbers, and synthesizing and evaluating the physical properties of organic EL materials. Research and development expenses were ¥262 million, and the research and development staff numbered 20.
  17. FY2021-Q3RestatedAnnual report

    「Research and development expenses for the third quarter cumulative period were ¥188 million. There were no material changes in the status of the Company's research and development activities during the third quarter cumulative period.」

    The Company disclosed research and development expenses of ¥188 million for the third quarter cumulative period, stating that there were no material changes in its research and development activities.
  18. FY2021-Q2RestatedAnnual report

    「Research and development expenses for the second quarter cumulative period were ¥127 million. There were no material changes in the status of the Company's research and development activities during the second quarter cumulative period.」

    The Company disclosed research and development expenses of ¥127 million for the second quarter cumulative period, stating that there were no material changes in its research and development activities.
  19. FY2021-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥72 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    The Company disclosed research and development expenses of ¥72 million for the first quarter cumulative period, stating that there were no material changes in its research and development activities.
  20. FY2020RestatedAnnual report

    「To expand its business and strengthen and stabilize its management base, the Company is promoting stronger collaboration with government and academic institutions, conducting research and development across a range of fields, including electronic materials such as ultraviolet absorbers and organic electroluminescent (organic EL) materials, and advancing the development of new products by fully utilizing its proprietary technologies.」

    The Company continued developing new products and production processes for ultraviolet absorbers, organic EL materials, and other products while strengthening collaboration with government and academic institutions. The research and development staff numbered 20, and research and development expenses were ¥250 million.
  21. FY2020-Q3RestatedAnnual report

    「Research and development expenses for the third quarter cumulative period were ¥184 million. There were no material changes in the status of the Company's research and development activities during the third quarter cumulative period.」

    The Company disclosed research and development expenses of ¥184 million for the third quarter cumulative period, stating that there were no material changes in its research and development activities.
  22. FY2020-Q2RestatedAnnual report

    「Research and development expenses for the second quarter cumulative period were ¥120 million. There were no material changes in the status of the Company's research and development activities during the second quarter cumulative period.」

    The Company disclosed research and development expenses of ¥120 million for the second quarter cumulative period, stating that there were no material changes in its research and development activities.
  23. FY2020-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥56 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    The Company disclosed research and development expenses of ¥56 million for the first quarter cumulative period, stating that there were no material changes in its research and development activities.
  24. FY2019-Q3RestatedAnnual report

    「Research and development expenses for the third quarter cumulative period were ¥190 million. There were no material changes in the status of the Company's research and development activities during the third quarter cumulative period.」

    The Company disclosed research and development expenses of ¥190 million for the third quarter cumulative period, stating that there were no material changes in its research and development activities.
  25. FY2019-Q2RestatedAnnual report

    「Research and development expenses for the second quarter cumulative period were ¥135 million. There were no material changes in the status of the Company's research and development activities during the second quarter cumulative period.」

    The Company disclosed research and development expenses of ¥135 million for the second quarter cumulative period, stating that there were no material changes in its research and development activities.
  26. FY2019-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥72 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    The Company disclosed first-quarter research and development expenses of ¥72 million, stating that there were no material changes in its research and development activities.
  27. FY2018RestatedAnnual report

    「During the fiscal year, the Company continued developing new products and production processes related to electronic materials, including ultraviolet absorbers and organic electroluminescent (organic EL) materials. For ultraviolet absorbers, it worked to improve production efficiency for benzotriazole, benzophenone, and triazine products. For organic EL materials, it conducted research and development into the synthesis of new materials, including electron-transport, hole-transport, luminescent, and host materials, as well as evaluation of their physical properties.」

    The Company continued developing new products and production processes, improving production efficiency, and synthesizing and evaluating the physical properties of organic EL materials. Research and development expenses were ¥302 million, and the research and development staff numbered 23.
  28. FY2018-Q2RestatedAnnual report

    「Research and development expenses for the second quarter cumulative period were ¥147 million. There were no material changes in the status of the Company's research and development activities during the second quarter cumulative period.」

    The Company disclosed research and development expenses of ¥147 million for the second quarter cumulative period, stating that there were no material changes in its research and development activities.
  29. FY2018-Q1RestatedAnnual report

    「Research and development expenses for the first quarter cumulative period were ¥74 million. There were no material changes in the status of the Company's research and development activities during the first quarter cumulative period.」

    The Company disclosed first-quarter research and development expenses of ¥74 million, stating that there were no material changes in its research and development activities.
  30. FY2017RestatedAnnual report

    「To expand its business and strengthen and stabilize its management base, the Company is engaged in research and development across a range of fields, including electronic materials such as ultraviolet absorbers and organic electroluminescent (organic EL) materials, and is advancing the development of new products by fully utilizing its proprietary technologies. The total research and development staff numbered 26, representing 11.7% of total employees. Total research and development expenses for the fiscal year were ¥308 million, equivalent to 3.4% of net sales.」

    The Company continued developing new products and production processes using proprietary technologies. The research and development staff numbered 26, and research and development expenses were ¥308 million.
  31. FY2016First statedAnnual report

    「To expand its business and strengthen and stabilize its management base, the Company is engaged in research and development across a range of fields, including electronic materials such as ultraviolet absorbers and organic electroluminescent (organic EL) materials, and is advancing the development of new products by fully utilizing its proprietary technologies.」

    The research and development staff numbered 30, and research and development expenses were ¥399 million. Activities included improving production efficiency for ultraviolet absorbers and synthesizing and evaluating the physical properties of organic EL materials.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Chemipro Kasei yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of New Products and Processes Using Proprietary Technologies | CHEMIPRO KASEI KAISHA,LTD. (4960) | Komori